Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jori Symons
Observed names:
J. Symons,
Symons, J.
Institution:
Amsterdam UMC Location University of Amsterdam
Observed institutions:
The Royal Melbourne Hospital,
The University of Melbourne,
Pfizer (United States),
Erasmus MC,
Amsterdam UMC Location University of Amsterdam,
University Medical Center Utrecht,
Peter Doherty Institute,
Pfizer (Netherlands),
University of Amsterdam
show all 9
ORCID:
0000-0003-0252-3887
Observed ORCID:
0000-0003-0252-3887
OpenAlex ID:
A5037065894
Functional Constraints of Influenza A Virus Epitopes Limit Escape from Cytotoxic T Lymphocytes
2005
·
E. G. M. Berkhoff
, E. de Wit
, et al.
·
Journal of Virology
·
112
HIV integration sites in latently infected cell lines: evidence of ongoing replication
2017
·
Jori Symons
, Abha Chopra
, et al.
·
Retrovirology
·
90
PDF
HIV integration sites and implications for maintenance of the reservoir
2017
·
Jori Symons
, Paul U. Cameron
, et al.
·
Current Opinion in HIV and AIDS
·
54
Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART
2021
·
Charline Bacchus-Souffan
, Mark Fitch
, et al.
·
PLoS Pathogens
·
52
PDF
Shock and kill within the CNS: A promising HIV eradication approach?
2022
·
Marieke M Nühn
, Stephanie B H Gumbs
, et al.
·
Journal of Leukocyte Biology
·
46
PDF
Efficacy and safety of an attenuated live QX-like infectious bronchitis virus strain as a vaccine for chickens
2011
·
H. J. Geerligs
, G.-J. Boelm
, et al.
·
Avian Pathology
·
46
CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4 + T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and Maintained
2019
·
Michael Roche
, Carolin Tumpach
, et al.
·
Journal of Virology
·
36
Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice
2011
·
J. Symons
, L. Vandekerckhove
, et al.
·
Clinical Microbiology and Infection
·
33
PDF
Development of a highly sensitive and specific intact proviral DNA assay for HIV-1 subtype B and C
2024
·
N. V. E. J. Buchholtz
, M. M. Nühn
, et al.
·
Virology Journal
·
27
PDF
Improved single-chain transactivators of the Tet-On gene expression system
2007
·
Xue Zhou
, Jori Symons
, et al.
·
BMC Biotechnology
·
26
PDF
Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome
2017
·
Thomas A. Rasmussen
, James McMahon
, et al.
·
AIDS
·
13
Selective decline of intact HIV reservoirs during the first decade of ART followed by stabilization in memory T cell subsets
2025
·
Marieke M. Nühn
, Kobus Bosman
, et al.
·
AIDS
·
12
Erratum to: HIV integration sites in latently infected cell lines: evidence of ongoing replication
2017
·
Jori Symons
, Abha Chopra
, et al.
·
Retrovirology
·
6
PDF
Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIV
2022
·
Matthew J. Gartner
, Carolin Tumpach
, et al.
·
AIDS
·
5
The cure of the 'Berlin patient': why did pre-existing X4-variants not emergence after allogeneic CCR5-Delta 32 SCT?
2012
·
Jori Symons
, Steven G. Deeks
, et al.
·
Journal of the International AIDS Society
·
5
Effect of triplicate testing on genotypic tropism prediction in routine clinical practice
2010
·
Jori Symons
, Linos Vandekerckhove
, et al.
·
Antiviral Therapy
·
2
HIV-specific CD8+ T-cell responses soon after treatment initiation during acute HIV infection are associated with viral reservoir decline
2025
·
Pien M van Paassen
, Alexander O Pasternak
, et al.
·
eLife
·
1
Author response: HIV-specific CD8+ T-cell proliferative response 24 weeks after early antiretroviral therapy initiation is associated with the subsequent reduction in the viral reservoir
2026
·
Pien Margien van Paassen
, Alexander O Pasternak
, et al.
·
eLife
PP 3.8 – 00137 Characterization of the HIV-1 subtype C reservoir during ART in South-African men and women
2022
·
N. Buchholtz
, L. Hermans
, et al.
·
Journal of Virus Eradication
PDF
Clonal integration site expansion of infected cells is a main contributor of HIV persistence in more differentiated T cell subsets during suppressive ART
2019
·
J. Symons
, C. Bacchus-Souffan
, et al.
·
Journal of Virus Eradication
PDF
The CCR5-agonist maraviroc reverses HIV latency, results from ex vivo studies and a randomized placebo controlled clinical trial
2017
·
J. Symons
, S.F.L. van Lelyveld
, et al.
·
Journal of Virus Eradication
PDF
31 High prevalence of CXCR4-using virus and low clonal expansion in infected naïve and central memory CD4+ T cells in individuals on ART
2017
·
M. Roche
, C. Tumpach
, et al.
·
Journal of Virus Eradication
PDF
Show more works
View as search
Works count:
24
Citation count:
567
H-index:
12
I10-index:
12
Year
Topic
Type